Top Markets
Coin of the day
Brainstorm Cell Therapeutics Inc. Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.

BCLI
Rang in Aktien #31762
Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to... Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to the development and commercialization of personalized, autologous cellular therapies. These innovative treatments are specifically designed to address neurodegenerative diseases. At the heart of its strategy is the proprietary NurOwn cell therapy platform. This platform employs sophisticated cell culture techniques to prompt mesenchymal stem cells, derived from the patient's own bone marrow, to produce high concentrations of neurotrophic factors. This process aims to regulate neuroinflammatory and neurodegenerative disease mechanisms, bolster the survival of neurons, and ultimately enhance neurological function. NurOwn is currently undergoing significant clinical development, having completed a Phase III clinical trial for Amyotrophic Lateral Sclerosis (ALS). Additionally, it has successfully advanced through Phase II clinical trials for both progressive multiple sclerosis and Alzheimer's disease, with potential applications being explored for other neurodegenerative conditions. To support its therapeutic pipeline, the company has established a manufacturing partnership with Catalent for NurOwn. Incorporated in 2000, the company initially operated as Golden Hand Resources Inc. before adopting the name Brainstorm Cell Therapeutics Inc. in November 2004. Its corporate headquarters are situated in New York, New York.
Aktienkurs
$1.10
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$12.14M
Veränderung (1 Tag)
11.11%
Veränderung (1 Jahr)
77.42%
Land
US
Handel Brainstorm Cell Therapeutics Inc. (BCLI)

Kategorie

Kursverlauf für Brainstorm Cell Therapeutics Inc. (BCLI)
Höchster Schlusskurs: $0.88 am 2026-08-01

Niedrigster Schlusskurs: $2.48 am 2003-05-01
Kursverlauf der Aktie von Brainstorm Cell Therapeutics Inc. von 2003 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 24.51%
2025 -68.88%
2024 -46.99%
2023 -85.62%
2022 -54.09%
2021 -29.58%
2020 29.82%
2019 25.11%
2018 -15.07%
2017 52.91%
2016 -12.65%
2015 -16.10%
2014 39.70%
2013 -30.92%
2012 -3.84%
2011 25.76%
2010 -23.27%
2009 193.77%
2008 -86.52%
2007 130.79%
2006 -53.34%
2005 -70.26%
2004 283.10%
2003 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$111.31 -36.83%
AU
$734.30 6.65%
CH
$1.06K -7.04%
KR